No products in the cart.

Chapter 56: Drugs for Women’s Reproductive Health and Menopause

Pharmacology A Patient Centered Nursing Process Approach 8th Edition-Kee -Hayes

$2.99

Chapter 56: Drugs for Women’s Reproductive Health and Menopause

 

Complete Chapter Questions With Answers

 

Sample Questions Are Posted Below

 

MULTIPLE CHOICE

 

  1. A woman is taking a combination oral contraceptive and asks the nurse why progestin is necessary. The nurse will explain that progestin helps prevent pregnancy by which method?
a. Altering the quantity and viscosity of cervical mucus
b. Inhibiting proliferative and secretory changes in the endometrium
c. Increasing motility of muscles and cilia in the fallopian tubes
d. Stimulating a surge in luteinizing hormone

 

 

ANS:  A

Progestin alters the quantity and viscosity of cervical mucus, making it thick and hostile to sperm penetration. Estrogen inhibits proliferative and secretory changes in the endometrium. Progestin decreases muscle and ciliary motility and decreases the LH surge.

 

DIF:    COGNITIVE LEVEL: Understanding (Comprehension)    REF:   Page 847

TOP:   NURSING PROCESS: Nursing Intervention

MSC:  NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies

 

  1. A woman will begin taking a combination oral contraceptive (COC) that has a higher estrogenic activity than her previous COC. When teaching this woman about the new product, the nurse will explain that she may experience which effect(s)?
a. Cyclic breast changes and chloasma
b. Decreased dysmenorrhea and menorrhagia
c. Decreased libido
d. Weight gain and fatigue

 

 

ANS:  A

Increased estrogenic activity may include side effects such as cyclic breast changes and chloasma as well as increased dysmenorrhea and menorrhagia. Increased progestin causes decreased libido, weight gain, and fatigue.

 

DIF:    COGNITIVE LEVEL: Understanding (Comprehension)    REF:   Page 847

TOP:   NURSING PROCESS: Nursing Intervention: Patient Teaching

MSC:  NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies

 

  1. A woman who has recently begun taking a combination oral contraceptive calls the clinic to report breakthrough bleeding. The nurse will
a. advise her to use a backup method of contraception.
b. counsel her to continue taking the contraceptive as prescribed.
c. recommend discussing an alternative contraceptive with her provider.
d. suggest that she perform a home pregnancy test to rule out pregnancy.

 

 

ANS:  B

Breakthrough bleeding is more common at the start of COC use, and there is no evidence that an episode of bleeding is associated with a decrease in the COC’s effectiveness as long as the patient continues to take the pill as prescribed. She does not need to use backup contraception. Unless the bleeding continues and is problematic, there is no need to change products. A pregnancy test is not indicated.

 

DIF:    COGNITIVE LEVEL: Applying (Application)                  REF:   Page 847

TOP:   NURSING PROCESS: Evaluation

MSC:  NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies

 

  1. A young woman who is taking Ortho-Tri-Cyclen for contraception tells the nurse that her provider has told her it will help to treat her acne. The nurse explains that this is because this product is
a. high in progestin.
b. low in androgenic activity.
c. low in estrogen.
d. triphasic.

 

 

ANS:  B

Products with low androgenic activity help to reduce acne.

 

DIF:    COGNITIVE LEVEL: Understanding (Comprehension)    REF:   Page 847

TOP:   NURSING PROCESS: Nursing Intervention: Patient Teaching

MSC:  NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies

 

Additional information

Add Review

Your email address will not be published. Required fields are marked *